On Jul. 19, LNC successfully held its first shareholders' meeting in 2023 at the headquarters of DC PHARMA. This meeting is the first formal shareholder meeting after the Series B financing of LNC. LNC’s shareholder representatives, LNC’s senior executives, some executives of DC PHARMA attended the meeting., and Mr. Luo Zhigang, Chairman of LNC, presided over the meeting.
The meeting first went through the deliberation of the shareholder meeting proposal, where the host read out the content of the proposal. Representatives of each shareholder carefully read and rigorously reviewed according to the rules and procedures, the relevant proposals were unanimously approved, LNC entered a new era of rapid development.
LNC’s General Manager Mr. Wu Xiaoming gave a detailed introduction to the progress, pipeline implementation, and future plans of the LNC projects to representatives of all shareholders at the meeting. After that, the attendees had sufficient communication and exchange. The representatives of all shareholders highly recognized the operation and management, especially giving full recognition to LNC's management teams for promoting the timely or even early achievement of milestones in all projects. All shareholder representatives unanimously believe that under the guidance of Prof. Chen Xiaoyuan and under the leadership of the management team headed by LNC's General Manager Mr. Wu Xiaoming, they are full of confidence that LNC's innovative R&D products can be launched as soon as possible to benefit patients.
Against the backdrop of strong national encouragement for the development of nuclear medicine, and relying on the policies of the nuclear medicine industry and the increasingly mature industrial environment, as well as the full nuclear medicine industry chain planning of DC PHARMA, LNC will adhere to the original intention of "Benefit People from Precision Therapy", continue to break through the radiopharmaceuticals R&D speed of LNC, and contribute to the development of the industry with a realistic, pragmatic, and efficient style.
